This is the authors' abstract. We don't add key points for this paper.
In 2016, Eidenschink Brodersen et al. from the Children’s Oncology Group (COG) described a new high-risk subtype of acute myeloid leukemia (AML) with a distinct immunophenotypic signature termed RA...
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wongworawat et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: